CD4 and tuberculosis: The Pred-ART randomized subjects to placebo or prednisone (40 mg for two weeks followed by 20 mg for two weeks) and found a 30% reduced incidence of TB-IRIS (RR 0.7) in persons with CD4 counts less than 100 cells/μL with prednisone [131].